The temperature controlled pharmaceutical containers market is set to enjoy a valuation of US$ 4.8 billion in 2024, registering progression at a CAGR of 4.8% to reach US$ 7.7 billion by 2034. Sales of such containers are anticipated to bolster with the top 3 countries estimated to hold around 35 to 40% of the market by the end of this forecast period.
Key Trends in the Temperature Controlled Pharmaceutical Container Market
| Report Attribute | Details |
|---|---|
| Temperature Controlled Pharmaceutical Container Market Size (2024) | US$ 4.8 billion |
| Market Anticipated Forecast Value (2034) | US$ 7.7 billion |
| Market Projected Growth Rate (2024 to 2034) | 4.8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per Future Market Insights (FMI), the temperature controlled pharmaceutical containers market witnessed a CAGR of 5.5% during the historic period with a market value of US$ 4.6 billion in 2023, growing from US$ 3.5 billion in 2019.
As many pharmacy companies started producing uncommon pharmaceuticals to combat the COVID-19 outbreak, the need for safe packaging surged during the years 2020 and 2021. Most of these medicines or drugs were sensitive to ambient temperature, resulting in cold chain logistics market trends hinging on temperature regulated pharmaceutical containers.
| Attributes | Details |
|---|---|
| Temperature Controlled Pharmaceutical Container Market Value (2019) | US$ 3.5 billion |
| Market Revenue (2023) | US$ 4.6 billion |
| Market Historical Growth Rate (CAGR 2019 to 2023) | 5.5% CAGR |
To ensure the safe delivery of critical products, service providers are now incorporating the latest technologies and launching innovative products. Further, as most temperature-sensitive medicines and vaccines are transported through airlines, vendors are entering into partnerships with leading airline and cargo companies.
The development of new drugs and therapies is expected to spur the industry growth factors for pharmaceutical containers. The market share of temperature controlled container brands meant for other commodities is also rising owing to the emergence of new pharmaceutical industries in developing economies.
Principal Consultant
A comparative analysis of two adjacent markets has been provided below. Market dynamics influencing pharmaceutical container sales globally can be considered pertinent for market players willing to diversify their product portfolio. Likewise, temperature controlled pharmaceutical packaging industry analysis suggests lucrative growth opportunities for the niche market.
Temperature Controlled Pharmaceutical Container Market:
| Attributes | Temperature Controlled Pharmaceutical Container Market |
|---|---|
| CAGR (2024 to 2034) | 4.8% |
| Growth Factor | The global pharmaceutical industry is witnessing high growth due to the increase in overall demand for effective medicines. |
| Market Opportunities | Increasing sales vaccines or drugs (iv) in pharma industry to create growth prospects for the market. |
| Market Challenges | Higher expense incurred from energy consumed in maintaining the internal temperature of containers. |
Pharmaceutical Container Market:
| Attributes | Pharmaceutical Container Market |
|---|---|
| CAGR (2024 to 2034) | 6.1% |
| Growth Factor | Due to the development of the pharmacy industry all over the world, particularly in emerging economies. |
| Market Opportunities | Temperature Controlled Pharmaceutical Container Vendors Partner with Leading Airlines. |
| Market Challenges | Trade barriers limiting the export of pharmaceuticals and challenges in sourcing raw materials or aluminum and iron metals. |
Temperature Controlled Pharmaceutical Packaging Solution Market:
| Attributes | Temperature Controlled Pharmaceutical Packaging Solution Market |
|---|---|
| CAGR (2024 to 2034) | 4.8% |
| Growth Factor | Shipping of pharmaceuticals in adherence to electromechanical temperatures with supportive logs facilitating its proper storage. |
| Market Opportunities | Increased waste of drugs or medications to propel the demand for temperature sensitive packaging solutions in the pharmacy industries. |
| Market Challenges | Stringent regulations regarding the use of plastic and other non-wetting polymers to hamper the market growth. |
Regional analysis of temperature controlled pharmaceutical container market figures out five countries with the most lucrative growth opportunities.
| Regional Market Comparison | CAGR (2024 to 2034) |
|---|---|
| United States | 2.9% |
| Germany | 2.5% |
| United Kingdom | 2.7% |
| China | 5.7% |
| India | 6% |
The United States temperature controlled pharmaceutical container market is witnessing growth trends that can exhibit a CAGR of 2.9% between 2024 and 2034. According to the International Federation of Pharmaceutical Manufacturers & Associations, the United States is currently the most developed pharmaceutical market across the globe.
The United States market is advancing fast due to higher investment in product design and the adoption of modern technologies to make it acceptable in other regions as well. The Pegasus ULD® from Sonoco ThermoSafe is the first passive bulk temperature-controlled ULD container for pharmaceutical use to receive FAA and EASA approval, allowing it to move quickly and cheaply through customs and handling procedures for international air freight.
Demand for temperature controlled pharmaceutical containers in Germany is poised to increase at a rate of 2.5% per year through the projected time period. Germany being the leading manufacturer of industrial equipment in Europe is now emphasizing more on logistics equipment for a quick return.
Technological advancements are enabling the regional players to meet the increasing consumer demand for new and more effective medicines and pharmaceutical products. Also, recent developments in HVAC technology are expected to prove helpful to German manufacturers to produce more efficient temperature-sensitive containers industry in the region.
The sales of temperature controlled pharmaceutical containers in the United Kingdom are poised to increase at 2.7% CAGR through 2034.
Using cloud technologies to gather, analyze, and visualize temperature data throughout transportation has boosted market perception and reliability of temperature controlled containers in the United Kingdom. Further, rising production and supply of life-saving drugs and vaccines across the country are expected to create lucrative prospects for the temperature controlled pharmaceutical container market.
The temperature controlled pharmaceutical container industry of China is on the path to achieve a CAGR of 5.7% over the forecast years. A sizable domestic market and export of pharmaceuticals have augmented the market forecast for the pharmaceutical container industry of the country.
Market forecasts for pharmaceutical container industries indicate a prolific rise in the regional market in China. In addition to that, with the presence of some leading pharmacy companies, market penetration strategies for temperature controlled containers are evolving fast in the country.
India has the 3rd largest pharmaceutical industry in terms of volume in comparison with all other countries across the globe. Hence, to keep the drugs safe from harsh temperatures and atmosphere, end users are increasing the adoption of temperature-controlled pharmaceutical containers.
With growing development in pharmaceutical manufacturing and supplying generic formulations across the globe, market trends driving innovation in pharmaceutical container solutions are expected to improve over the forecast period. So, sales of temperature controlled pharmaceutical containers in India are expected to develop at a 6% CAGR between 2024 and 2034.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Based on product type, the chest style segment accounts for more than 75.5% of the market value share in 2024.
| Attributes | Details |
|---|---|
| Top Product Type Segment | Chest Style |
| Total Market Share in 2024 to 2034 | 75.5% |
Due to the higher thermal stability and operational qualification of chest-style containers, the product is gaining popularity. These systems are secure and allow users to quickly load and unload. Moreover, chest-style containers with active systems are temperature-controlled containers with monitoring systems that function with the help of electricity.
Based on application chilled containers segment is figured to contribute to 42.9% of the total market sales in 2024.
| Attributes | Details |
|---|---|
| Top Application Type Segment | Chilled |
| Total Market Share in 2024 | 42.9% |
Temperature-controlled containers are designed to maintain temperature surroundings during the transportation of medical and drug supplies across the globe. Market research on temperature control technologies in containers also suggests chilled containers are more economical than other temperature containers. Hence, chilled containers are adopted more by pharmaceutical manufacturers to cater to the growing demand among patients and the rise of routine diseases.
Key players operating in the temperature-controlled pharmaceutical containers market are aiming to expand their production capabilities to meet the growing demand. They are also forming alliances and eyeing acquisition strategies to expand their resources. Meanwhile, some emerging players are developing new products to meet customer needs and gain a competitive edge. Also, these companies are focusing on upgrading their facilities to cater to the demand.
Recent Developments
| Attribute | Details |
|---|---|
| Estimated Market Size (2024) | US$ 4.8 billion |
| Projected Market Size (2034) | US$ 7.7 billion |
| Anticipated Growth Rate (2024 to 2034) | 4.8% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | US$ million or billion for Value and Units for Volume |
| Key Regions Covered | North America; Latin America; Europe; Middle East & Africa (MEA); East Asia; South Asia and Oceania |
| Key Countries Covered | United States, Canada, Brazil, Mexico, Germany, Spain, Italy, France, United Kingdom, Russia, China, India, Australia & New Zealand, GCC Countries, and South Africa |
| Key Segments Covered | By Product Type, By Application, By Control Type, By Content Type, and By Region |
| Key Companies Profiled | Pelican Biothermal; Sonoco Product Company; Cryopak; Cold Chain Technologies; Envirotainer Ltd; Sofigram SA Ltd; Va Q Tec AG; Inmark Packaging; Softbox Systems; Sealed Air Corporation; Tempack; Intelsius; Saeplast Americas Inc.; Euroengel Srl; Klinge Corporation |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available Upon Request |
The market is estimated to be around US$ 4.8 billion in 2024.
The market is set to progress at a 4.8% CAGR during the forecast period.
The market is predicted to be valued at US$ 7.7 billion by 2034.
The market was valued at US$ 3.5 billion in 2019.
India to follow 6% CAGR in sales of temperature controlled pharmaceutical containers through 2034.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Manufacturer 3.5.1.2. Mid-Level Participants 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Control Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Control Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Control Type, 2024 to 2034 5.3.1. Active 5.3.2. Passive 5.4. Y-o-Y Growth Trend Analysis By Control Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Control Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Form 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Form, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Form, 2024 to 2034 6.3.1. Chest Style 6.3.2. Upright Style 6.4. Y-o-Y Growth Trend Analysis By Form, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Form, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2024 to 2034 7.3.1. Frozen 7.3.2. Chilled 7.3.3. Ambient 7.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Content Type 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Content Type, 2019 to 2023 8.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Content Type, 2024 to 2034 8.3.1. Vaccines/Drugs (IV) 8.3.2. Samples (Blood, Biopsy, Etc.) 8.3.3. Reagents 8.3.4. Genetic Materials 8.4. Y-o-Y Growth Trend Analysis By Content Type, 2019 to 2023 8.5. Absolute $ Opportunity Analysis By Content Type, 2024 to 2034 9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2019 to 2023 9.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034 9.3.1. North America 9.3.2. Latin America 9.3.3. Western Europe 9.3.4. Eastern Europe 9.3.5. South Asia and Pacific 9.3.6. East Asia 9.3.7. Middle East and Africa 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. USA 10.2.1.2. Canada 10.2.2. By Control Type 10.2.3. By Form 10.2.4. By Application 10.2.5. By Content Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Control Type 10.3.3. By Form 10.3.4. By Application 10.3.5. By Content Type 10.4. Key Takeaways 11. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Control Type 11.2.3. By Form 11.2.4. By Application 11.2.5. By Content Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Control Type 11.3.3. By Form 11.3.4. By Application 11.3.5. By Content Type 11.4. Key Takeaways 12. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. UK 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Western Europe 12.2.2. By Control Type 12.2.3. By Form 12.2.4. By Application 12.2.5. By Content Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Control Type 12.3.3. By Form 12.3.4. By Application 12.3.5. By Content Type 12.4. Key Takeaways 13. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. Poland 13.2.1.2. Russia 13.2.1.3. Czech Republic 13.2.1.4. Romania 13.2.1.5. Rest of Eastern Europe 13.2.2. By Control Type 13.2.3. By Form 13.2.4. By Application 13.2.5. By Content Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Control Type 13.3.3. By Form 13.3.4. By Application 13.3.5. By Content Type 13.4. Key Takeaways 14. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. India 14.2.1.2. Bangladesh 14.2.1.3. Australia 14.2.1.4. New Zealand 14.2.1.5. Rest of South Asia and Pacific 14.2.2. By Control Type 14.2.3. By Form 14.2.4. By Application 14.2.5. By Content Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Control Type 14.3.3. By Form 14.3.4. By Application 14.3.5. By Content Type 14.4. Key Takeaways 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. China 15.2.1.2. Japan 15.2.1.3. South Korea 15.2.2. By Control Type 15.2.3. By Form 15.2.4. By Application 15.2.5. By Content Type 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Control Type 15.3.3. By Form 15.3.4. By Application 15.3.5. By Content Type 15.4. Key Takeaways 16. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 16.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023 16.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034 16.2.1. By Country 16.2.1.1. GCC Countries 16.2.1.2. South Africa 16.2.1.3. Israel 16.2.1.4. Rest of MEA 16.2.2. By Control Type 16.2.3. By Form 16.2.4. By Application 16.2.5. By Content Type 16.3. Market Attractiveness Analysis 16.3.1. By Country 16.3.2. By Control Type 16.3.3. By Form 16.3.4. By Application 16.3.5. By Content Type 16.4. Key Takeaways 17. Key Countries Market Analysis 17.1. USA 17.1.1. Pricing Analysis 17.1.2. Market Share Analysis, 2023 17.1.2.1. By Control Type 17.1.2.2. By Form 17.1.2.3. By Application 17.1.2.4. By Content Type 17.2. Canada 17.2.1. Pricing Analysis 17.2.2. Market Share Analysis, 2023 17.2.2.1. By Control Type 17.2.2.2. By Form 17.2.2.3. By Application 17.2.2.4. By Content Type 17.3. Brazil 17.3.1. Pricing Analysis 17.3.2. Market Share Analysis, 2023 17.3.2.1. By Control Type 17.3.2.2. By Form 17.3.2.3. By Application 17.3.2.4. By Content Type 17.4. Mexico 17.4.1. Pricing Analysis 17.4.2. Market Share Analysis, 2023 17.4.2.1. By Control Type 17.4.2.2. By Form 17.4.2.3. By Application 17.4.2.4. By Content Type 17.5. Germany 17.5.1. Pricing Analysis 17.5.2. Market Share Analysis, 2023 17.5.2.1. By Control Type 17.5.2.2. By Form 17.5.2.3. By Application 17.5.2.4. By Content Type 17.6. UK 17.6.1. Pricing Analysis 17.6.2. Market Share Analysis, 2023 17.6.2.1. By Control Type 17.6.2.2. By Form 17.6.2.3. By Application 17.6.2.4. By Content Type 17.7. France 17.7.1. Pricing Analysis 17.7.2. Market Share Analysis, 2023 17.7.2.1. By Control Type 17.7.2.2. By Form 17.7.2.3. By Application 17.7.2.4. By Content Type 17.8. Spain 17.8.1. Pricing Analysis 17.8.2. Market Share Analysis, 2023 17.8.2.1. By Control Type 17.8.2.2. By Form 17.8.2.3. By Application 17.8.2.4. By Content Type 17.9. Italy 17.9.1. Pricing Analysis 17.9.2. Market Share Analysis, 2023 17.9.2.1. By Control Type 17.9.2.2. By Form 17.9.2.3. By Application 17.9.2.4. By Content Type 17.10. Poland 17.10.1. Pricing Analysis 17.10.2. Market Share Analysis, 2023 17.10.2.1. By Control Type 17.10.2.2. By Form 17.10.2.3. By Application 17.10.2.4. By Content Type 17.11. Russia 17.11.1. Pricing Analysis 17.11.2. Market Share Analysis, 2023 17.11.2.1. By Control Type 17.11.2.2. By Form 17.11.2.3. By Application 17.11.2.4. By Content Type 17.12. Czech Republic 17.12.1. Pricing Analysis 17.12.2. Market Share Analysis, 2023 17.12.2.1. By Control Type 17.12.2.2. By Form 17.12.2.3. By Application 17.12.2.4. By Content Type 17.13. Romania 17.13.1. Pricing Analysis 17.13.2. Market Share Analysis, 2023 17.13.2.1. By Control Type 17.13.2.2. By Form 17.13.2.3. By Application 17.13.2.4. By Content Type 17.14. India 17.14.1. Pricing Analysis 17.14.2. Market Share Analysis, 2023 17.14.2.1. By Control Type 17.14.2.2. By Form 17.14.2.3. By Application 17.14.2.4. By Content Type 17.15. Bangladesh 17.15.1. Pricing Analysis 17.15.2. Market Share Analysis, 2023 17.15.2.1. By Control Type 17.15.2.2. By Form 17.15.2.3. By Application 17.15.2.4. By Content Type 17.16. Australia 17.16.1. Pricing Analysis 17.16.2. Market Share Analysis, 2023 17.16.2.1. By Control Type 17.16.2.2. By Form 17.16.2.3. By Application 17.16.2.4. By Content Type 17.17. New Zealand 17.17.1. Pricing Analysis 17.17.2. Market Share Analysis, 2023 17.17.2.1. By Control Type 17.17.2.2. By Form 17.17.2.3. By Application 17.17.2.4. By Content Type 17.18. China 17.18.1. Pricing Analysis 17.18.2. Market Share Analysis, 2023 17.18.2.1. By Control Type 17.18.2.2. By Form 17.18.2.3. By Application 17.18.2.4. By Content Type 17.19. Japan 17.19.1. Pricing Analysis 17.19.2. Market Share Analysis, 2023 17.19.2.1. By Control Type 17.19.2.2. By Form 17.19.2.3. By Application 17.19.2.4. By Content Type 17.20. South Korea 17.20.1. Pricing Analysis 17.20.2. Market Share Analysis, 2023 17.20.2.1. By Control Type 17.20.2.2. By Form 17.20.2.3. By Application 17.20.2.4. By Content Type 17.21. GCC Countries 17.21.1. Pricing Analysis 17.21.2. Market Share Analysis, 2023 17.21.2.1. By Control Type 17.21.2.2. By Form 17.21.2.3. By Application 17.21.2.4. By Content Type 17.22. South Africa 17.22.1. Pricing Analysis 17.22.2. Market Share Analysis, 2023 17.22.2.1. By Control Type 17.22.2.2. By Form 17.22.2.3. By Application 17.22.2.4. By Content Type 17.23. Israel 17.23.1. Pricing Analysis 17.23.2. Market Share Analysis, 2023 17.23.2.1. By Control Type 17.23.2.2. By Form 17.23.2.3. By Application 17.23.2.4. By Content Type 18. Market Structure Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Market Share Analysis of Top Players 18.3.1. By Regional 18.3.2. By Control Type 18.3.3. By Form 18.3.4. By Application 18.3.5. By Content Type 19. Competition Analysis 19.1. Competition Deep Dive 19.1.1. Pelican Biothermal 19.1.1.1. Overview 19.1.1.2. Product Portfolio 19.1.1.3. Profitability by Market Segments 19.1.1.4. Sales Footprint 19.1.1.5. Strategy Overview 19.1.1.5.1. Marketing Strategy 19.1.1.5.2. Product Strategy 19.1.1.5.3. Channel Strategy 19.1.2. Sonoco Product Company 19.1.2.1. Overview 19.1.2.2. Product Portfolio 19.1.2.3. Profitability by Market Segments 19.1.2.4. Sales Footprint 19.1.2.5. Strategy Overview 19.1.2.5.1. Marketing Strategy 19.1.2.5.2. Product Strategy 19.1.2.5.3. Channel Strategy 19.1.3. Cryopak 19.1.3.1. Overview 19.1.3.2. Product Portfolio 19.1.3.3. Profitability by Market Segments 19.1.3.4. Sales Footprint 19.1.3.5. Strategy Overview 19.1.3.5.1. Marketing Strategy 19.1.3.5.2. Product Strategy 19.1.3.5.3. Channel Strategy 19.1.4. Cold Chain Technologies 19.1.4.1. Overview 19.1.4.2. Product Portfolio 19.1.4.3. Profitability by Market Segments 19.1.4.4. Sales Footprint 19.1.4.5. Strategy Overview 19.1.4.5.1. Marketing Strategy 19.1.4.5.2. Product Strategy 19.1.4.5.3. Channel Strategy 19.1.5. Envirotainer Ltd 19.1.5.1. Overview 19.1.5.2. Product Portfolio 19.1.5.3. Profitability by Market Segments 19.1.5.4. Sales Footprint 19.1.5.5. Strategy Overview 19.1.5.5.1. Marketing Strategy 19.1.5.5.2. Product Strategy 19.1.5.5.3. Channel Strategy 19.1.6. Sofigram SA Ltd 19.1.6.1. Overview 19.1.6.2. Product Portfolio 19.1.6.3. Profitability by Market Segments 19.1.6.4. Sales Footprint 19.1.6.5. Strategy Overview 19.1.6.5.1. Marketing Strategy 19.1.6.5.2. Product Strategy 19.1.6.5.3. Channel Strategy 19.1.7. Inmark Packaging 19.1.7.1. Overview 19.1.7.2. Product Portfolio 19.1.7.3. Profitability by Market Segments 19.1.7.4. Sales Footprint 19.1.7.5. Strategy Overview 19.1.7.5.1. Marketing Strategy 19.1.7.5.2. Product Strategy 19.1.7.5.3. Channel Strategy 19.1.8. Softbox Systems 19.1.8.1. Overview 19.1.8.2. Product Portfolio 19.1.8.3. Profitability by Market Segments 19.1.8.4. Sales Footprint 19.1.8.5. Strategy Overview 19.1.8.5.1. Marketing Strategy 19.1.8.5.2. Product Strategy 19.1.8.5.3. Channel Strategy 19.1.9. Sealed Air Corporation 19.1.9.1. Overview 19.1.9.2. Product Portfolio 19.1.9.3. Profitability by Market Segments 19.1.9.4. Sales Footprint 19.1.9.5. Strategy Overview 19.1.9.5.1. Marketing Strategy 19.1.9.5.2. Product Strategy 19.1.9.5.3. Channel Strategy 19.1.10. Tempack 19.1.10.1. Overview 19.1.10.2. Product Portfolio 19.1.10.3. Profitability by Market Segments 19.1.10.4. Sales Footprint 19.1.10.5. Strategy Overview 19.1.10.5.1. Marketing Strategy 19.1.10.5.2. Product Strategy 19.1.10.5.3. Channel Strategy 19.1.11. Intelsius 19.1.11.1. Overview 19.1.11.2. Product Portfolio 19.1.11.3. Profitability by Market Segments 19.1.11.4. Sales Footprint 19.1.11.5. Strategy Overview 19.1.11.5.1. Marketing Strategy 19.1.11.5.2. Product Strategy 19.1.11.5.3. Channel Strategy 19.1.12. Saeplast Americas Inc. 19.1.12.1. Overview 19.1.12.2. Product Portfolio 19.1.12.3. Profitability by Market Segments 19.1.12.4. Sales Footprint 19.1.12.5. Strategy Overview 19.1.12.5.1. Marketing Strategy 19.1.12.5.2. Product Strategy 19.1.12.5.3. Channel Strategy 20. Assumptions & Acronyms Used 21. Research Methodology
Packaging
February 2022
REP-GB-1446
February 2024
200 pages
Explore Packaging Insights
View Reports
Temperature Controlled Pharmaceutical Container Market
